Tech Company Financing Transactions

PathologyWatch Funding Round

PathologyWatch, operating out of Salt Lake City, secured $25 million in investment from Blackbrook Management, Blueprint Health and Ceros.

Transaction Overview

Company Name
Announced On
11/17/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

Blackbrook Management

Blueprint Health

Ceros

Rock Creek Capital (Rick Stratford)

Spark Growth Ventures

SpringTide Ventures (Austin Walters)

Proceeds Purpose
With the new funding, PathologyWatch will broaden its outreach to dermatologists and conduct further research into skincare diagnostics and AI -- allowing patients to receive faster diagnoses and more equitable access to dermatopathology services while enabling labs to work more efficiently and cost-effectively.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
166 East 5900 South B104
Salt Lake City, UT 84107
USA
Email Address
Overview
PathologyWatch is working with clinical dermatology practices like yours to manage your pathology workflow using a digital model. This helps to improve the quality of patient care, reduce costs, and open up new potential steams of revenue for clinics and hospitals.
Profile
PathologyWatch LinkedIn Company Profile
Social Media
PathologyWatch Company Twitter Account
Company News
PathologyWatch News
Facebook
PathologyWatch on Facebook
YouTube
PathologyWatch on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Lambert
  Daniel Lambert LinkedIn Profile  Daniel Lambert Twitter Account  Daniel Lambert News  Daniel Lambert on Facebook
Chief Medical Officer
Gregory Osmond
  Gregory Osmond LinkedIn Profile  Gregory Osmond Twitter Account  Gregory Osmond News  Gregory Osmond on Facebook
VP - Bus. Development
Michael Torno
  Michael Torno LinkedIn Profile  Michael Torno Twitter Account  Michael Torno News  Michael Torno on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/17/2021: Dubit venture capital transaction
Next: 11/17/2021: Goody Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary